CME and the pharmaceutical industry: Two worlds, three views, four steps

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 2, 2004, Pages 149-150

  Davis, David A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; COMORBIDITY; CONTINUING EDUCATION; DECISION MAKING; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HUMAN; MEDICAL EDUCATION; NOTE; PRACTICE GUIDELINE; CANADA; ECONOMICS; MEDICAL SCHOOL; ORGANIZATION AND MANAGEMENT;

CANADA; DECISION MAKING; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; HUMANS; SCHOOLS, MEDICAL;

EID: 3442890884     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1040361     Document Type: Note

References (14)

1. Relman AS. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. JAMA 2003;289:2418-20.
2. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 2000;283:373-80.
3. Code of marketing practices. Ottawa: Canada's Research-Based Pharmaceutical Companies; revised Jan 2004. Available: www.canadapharma.org/ Industry_Publications /Code/Code_of_markering-ENJan2004.pdf (accessed 2004 April 6).
4. Society for Academic Continuing Medical Education. Biennial survey. Available: www.sacme.org/Biennial_Survey/default.htm (accessed 2004 April 6).
5. Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say? CMAJ 1993;149(10):1401-7.
6. Relman AS, Angell M. America's other drug problem. N Republic 2002;27-41.
7. Coyle SL; Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 1: individual physicians. Ann Intern Med 2002;136(5):396-402.
8. Coyle SL; Ethics and Human Rights Committee, American College of Physicians-American Society of Internal Medicine. Physician-industry relations. Part 2: organizational issues. Ann Intern Med 2002;136(5):403-6.
9. Steward DE. A proposal to enhance the disclosure of potential conflict of interest for continuing medical education events. Teach Learn Med 2003;15(4):267-9.
10. What's wrong with CME? [editorial] CMAJ 2004;170(6):917.
11. Guideline Advisory Committee. Recommended clinical practice guidelines. Available: www.gacguidelines.ca (accessed 2004 April 6).
12. Health Canada. Primary Care Transition Fund. Available: www.hc-sc.gc.ca /phctf-fassp (accessed 2004 April 6).
13. Policy on support of University of Toronto sponsored continuing education activities from commercial sources. Toronto: University of Toronto; 1999. Available: www.library.utoronto.ca/medicine/staff_info/Commercial_Support.pdf (accessed 2004 April 6).
14. Accreditation Council for Continuing Medical Education. Standards for commercial support. Standards to ensure the independence of CME activities. Available: www.accme.org/incoming/ 174_Standards%20for%20Commercial%20Support_April%202004.pdf (accessed 2004 April 6).